Facilities
February 4, 2026
DalterFood Group Opens New Parma Packaging Facility Following Record €200M Revenue Year
The opening comes as the company confirms it closed 2025 with a turnover of €200 million, a milestone that underscores the solidity of its business model amidst growing global demand for high-quality hard cheeses.
February 3, 2026
Fonterra Breaks Ground on $75M Butter Plant Expansion to Drive High-Value Milkfat Strategy
This expansion is a key component of Fonterra’s committed capital investment plan, which allocates up to $1 billion over the next three to four years towards projects that drive operational efficiency and generate value-added growth.
January 27, 2026
JPL Flavours Opens £11m Innovation HQ in Bromborough to Scale UK Manufacturing
UK flavour manufacturer JPL Flavours has officially inaugurated its new global headquarters in Bromborough, Wirral, following an £11 million investment.
January 27, 2026
Re:Water Invests £2m in New Herefordshire Facility to Scale Aluminium Bottled Water Production
Aluminium bottled water brand Re:Water, owned by Berrington Pure Spring Water, has announced a capital investment of £2 million to construct a new production facility in Herefordshire.
January 25, 2026
Arla Foods and XPO Logistics to Centralise UK Chilled Network with New Northamptonshire CDC
Currently under development at Prologis RFI DIRFT in Northamptonshire, the facility is scheduled to become operational in late 2027. XPO Logistics has been appointed to project manage the build and will subsequently operate the site.
January 25, 2026
Alpenrose to Cease Production at Clackamas Facility in Operational Consolidation
Pacific Northwest dairy brand Alpenrose has announced a major restructuring of its manufacturing footprint, confirming plans to cease production at its facility in Clackamas, Oregon, effective 31 March 2026.
January 16, 2026
New Wave Biotech Partners with Temasek’s Nurasa to Digitise Bioprocess Scaling in Asia
The partnership addresses critical bottlenecks in the biomanufacturing sector, specifically the high cost and time constraints associated with scaling products from the laboratory to industrial viability.
- Page 5










